Ignite Creation Date:
2025-12-24 @ 10:22 PM
Ignite Modification Date:
2026-01-01 @ 4:17 PM
Study NCT ID:
NCT04776135
Status:
COMPLETED
Last Update Posted:
2024-01-08
First Post:
2021-02-25
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Comparative Bioavailability Study of Oral Edaravone Administered Orally and Via a Nasogastric Tube
Sponsor:
Tanabe Pharma Corporation
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-02-26
Start Date Type:
ACTUAL
Primary Completion Date:
2021-04-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-04-16
Completion Date Type:
ACTUAL
First Submit Date:
2021-02-25
First Submit QC Date:
None
Study First Post Date:
2021-03-01
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-03-17
Results First Submit QC Date:
None
Results First Post Date:
2024-01-08
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-01-05
Last Update Post Date:
2024-01-08
Last Update Post Date Type:
ACTUAL